150例老年重度慢性心力衰竭用药情况分析  

Medication treatment of 150 elderly patients with serious chronic congestive heart failure

作　　者：王路宏[1] 白爱萍[1] 刘俊青[1] 原景[1] 

机构地区：[1]北京中医药大学附属护国寺中医院老年病房,100035

出　　处：《中华全科医师杂志》2008年第10期699-700,共2页Chinese Journal of General Practitioners

摘　　要：总结1986年、1996年、2006年老年重度慢性心力衰竭反复住院患者150例的临床资料，分析患者入院前后用药情况，平均住院天数及住院问隔时间。结果显示20世纪90年代以前洋地黄制剂、利尿剂和血管扩张剂使用率分别为100％，≥95％及〉50％；β受体阻滞剂使用率〈10％；血管紧张素转化酶抑制剂（ACEI）或血管紧张素受体拮抗剂（ARB）使用率为零。90年代以后β受体阻滞剂、ACEI或ARB类药物使用率逐年提高，用药变化后患者住院时间缩短，再住院时间间隔延长（P〈0．01）。提示老年慢性心力衰竭治疗也应遵循循证医学原则有效、合理用药。We retrospectively reviewed clinical data of 150 elderly patients with serious chronic congestive heart failure who admitted in 1986, 1996 or ：2006, including medication treatment, hospital stay, and admission interval. The results indicated that before 1990s, digitalis, diuretics, and blood vessel dilating agents were more often used in the treatment of chronic congestive heart failure （ digitalis = 100%, diuretics i〉95% , blood vessel dilating agents 〉 50% , β-blocker 〈 10%, ACEI/ARB = 0% ）. Since 1990s, the use of β-blocker, ACEI and ARB increased, which resulted in reduced hospital stay and increased admission interval（P 〈0.01）. Our investigation suggests that evidence-based medication could be necessary in the treatment of elderly patients with chronic congestive heart failure.

关 键 词：心力衰竭 充血性 老年人 

分 类 号：R541.6[医药卫生—心血管疾病]